86 search results for Lung
Policy Toolkit_September 2021
LungCancer MultipleMyeloma (Portuguese) Non-SmallCell LungCancer EnhancedLevel NCCN Digital
https://www.nccn.org/docs/default-source/oncology-policy-program/policy-toolkit_september-2021.pdf?sfvrsn=c54522e6_2Advocacy and Support Groups
Cancer Lung Cancer Melanoma/Skin Cancer Mesothelioma Myelodysplastic Syndromes Myeloma, myeloma, metastatic breast cancer, and lung cancer (non-small cell). Since 2004, PAN has provided, cancers—including lung, breast, prostate, colorectal, cervical, skin, oral and testicular—that can, cancer, and lung cancer (non-small cell). Since 2004, PAN has provided nearly $400 million
https://www.nccn.org/patientresources/patient-resources/resources-for-patients-caregivers/advocacy-and-support-groupsGuidelines for Patients Translations
Lung Cancer - Early and Locally Advanced Version 2024 (Arabic) Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (Arabic) Guidelines for Patients, Version 2024 (Arabic) Guidelines for Patients® Small Cell Lung Cancer Version 2024, Cell Lung Cancer - Early and Locally Advanced Version 2024 (Chinese) Guidelines for Patients® Non-Small Cell Lung Cancer - Metastatic Version 2024 (Chinese) Guidelines
https://www.nccn.org/global/what-we-do/guidelines-for-patients-translationsDownload the Understanding Immunotherapy Side Effects Infographic (English).
. Joints Joint pain or swelling, stiffness after rest, improvement with activity Lungs Shortness
https://www.nccn.org/docs/default-source/patient-resources/immunotherapy_infographic.pdf?sfvrsn=f92249ca_36Scientific Publications
. doi: 10.1038/s41416-020-0737-6. Epub 2020 Feb 10.https://pubmed.ncbi.nlm.nih.gov/32037403/ Lung, in molecularly selected patients with advanced non-small cell lung cancer. J Thorac Dis 2024. doi, , and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non–Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked. Clinical Lung Cancer Published:May 10, 2023 DOI:https://doi.org/10.1016/j.cllc.2023.05.003. https://www.clinical-lung-cancer.com
https://www.nccn.org/education-research/nccn-oncology-research-program/scientific-publicationsClinical Guidelines Translations
) Multiple Myeloma Version 5.2022 (Arabic) Non-Small Cell Lung Cancer Version, Cancer Version 4.2022 (Chinese) Small Cell Lung Cancer Version 1.2023 (Chinese, ) Multiple Myeloma Version 5.2022 (French) Non-Small Cell Lung Cancer Version, ) Multiple Myeloma Version 5.2022 (Italian) Non-Small Cell Lung Cancer Version 3.2023, ) Non-Small Cell Lung Cancer Version 3.2023 (Japanese) Waldenström
https://www.nccn.org/global/what-we-do/clinical-guidelines-translationsJNCCN
IN THIS ISSUE NCCN Guidelines® Insights | CE Lung Cancer Screening, Version, . Advanced Skin Cancers Breast Cancer CLL/MCL Immunotherapy Non-Small Cell Lung Cancer Ovarian, Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines, Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice
https://www.nccn.org/home/jnccnNCCN History
for the following disease types: Acute Leukemia and Breast, Colon, Lung, Ovarian, Pediatric, launches its first live webinar program, NCCN Oncology Case Management Program™: Non-Small Cell Lung
https://www.nccn.org/home/about/nccn-historyClinical Trials
-trastuzumab deruxtecan in advanced refractory gastrointestinal cancer patients Lung Cancer Yasir, EGFR Mutant Lung Cancer Nicholas Bodor, MD, PhD, MPH Fox Chase Cancer Center TH-138: Phase II
https://www.nccn.org/education-research/nccn-oncology-research-program/clinical-trialsWebinars for Patients
to view afterward. Upcoming Live Webinars Small Cell Lung Cancer - Monday, April 21, 2025 Register Now Recorded Webinars Why Should I Consider a Clinical Trial? (2025) Non-Small Cell Lung Cancer (NSCLC, resources, breast cancer, lung cancer, recorded webinars, recorded patient webinar, myeloma, lymphoma
https://www.nccn.org/patientresources/patient-resources/patient-webinarsImaging AUC Compendium Reviewer Acknowledgement
Institute at the University of Utah Lung Cancer Screening Ella, Cancer Hospital Small Cell Lung Cancer Apar Kishor P. Ganti
https://www.nccn.org/compendia-templates/compendia/imaging-appropriate-use-criteria-nccn-imaging-auc/imaging-auc-compendium-reviewer-acknowledgementGuidelines for Patients
Version: 2022 Non-Small Cell Lung Cancer - Early, -Small Cell Lung Cancer - Metastatic Version: 2024, Cell Lung Cancer Version: 2024 Soft, Cancers Version: 2025 Lung Cancer Screening, cancer resources, prostate cancer resources, lung cancer resources, immunotherapy information, lung
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patientsNCCN Continuing Education Portal
Boards: New Approaches to the Management of Resectable Non-Small Cell Lung Cancer 1.00 AAPA
https://www.nccn.org/education-research/continuing-education-(ce)/continuing-educationCollaborators
AssociationAmerican Cancer Society, Inc.American Head & Neck Society (AHNS)American Lung AssociationAmerican Lung Cancer Screening Initiative (ALCSI)American Thyroid AssociationAnal Cancer, QuebecFORCE: Facing Our Risk of Cancer EmpoweredFoundation for Women's CancerFree ME from Lung, Liver InstituteGlobal Resource for Advancing Cancer EducationGo2 Foundation for Lung CancerGood, Breast Cancer Research FoundationInternational Association for the Study of Lung Cancer (IASLC
https://www.nccn.org/patientresources/patient-resources/nccn-foundation/collaboratorsBiomarkers Compendium Reviewer Acknowledgment
Vanderbilt-Ingram Cancer Center Non-Small Cell Lung Cancer, , MD Memorial Sloan Kettering Cancer Center Small Cell Lung Cancer
https://www.nccn.org/compendia-templates/compendia/biomarkers-compendium/biomarkers-compendium-reviewer-acknowledgmentTreatment by Cancer Type
Care Specific Populations All Breast Cancer Resources All Lung Cancer Resources, Version: 2022 Non-Small Cell Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer, Version: 2024 Small Cell Lung Cancer, Version: 2025 Lung Cancer Screening
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/treatment-by-cancer-typeDetection, Prevention, and Risk Reduction
Care Specific Populations All Breast Cancer Resources All Lung Cancer Resources, Version: 2022 Non-Small Cell Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer, Version: 2024 Small Cell Lung Cancer, Version: 2025 Lung Cancer Screening
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/detection-prevention-and-risk-reductionSupportive Care
Care Specific Populations All Breast Cancer Resources All Lung Cancer Resources, Version: 2022 Non-Small Cell Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer, Version: 2024 Small Cell Lung Cancer, Version: 2025 Lung Cancer Screening
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/supportive-careSpecific Populations
Care Specific Populations All Breast Cancer Resources All Lung Cancer Resources, Version: 2022 Non-Small Cell Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer, Version: 2024 Small Cell Lung Cancer, Version: 2025 Lung Cancer Screening
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/specific-populationsRecently Updated Guidelines
Neuroendocrine and Adrenal Tumors Version 4.2024 Non-Small Cell Lung Cancer Version 3.2025, Small Cell Lung Cancer Version 4.2025 Squamous Cell Skin Cancer Version 1.2025
https://www.nccn.org/guidelines/recently-published-guidelines